We respond to government funding announcement for early career researchers supported by charities
Responding to the Department for Business, Energy and Industrial Strategy's (BEIS) announcement of funding for early career researchers supported by charities.
08 Jun 2021
We respond to the announcement of more than £25m being invested in diagnostic equipment for NHS Wales
Mia Rosenblatt, Associate Director of Evidence, Policy and Influencing at Breast Cancer Now, said:
03 Jun 2021
We respond to NHS Breast Screening Programme Statistics for Scotland 2017/18 to 2019/20
Mia Rosenblatt, Associate Director of Evidence, Policy and Influencing at Breast Cancer Now, said:
01 Jun 2021
We respond to NHS England breast cancer waiting times: March 2021
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
13 May 2021
We respond to the Clinical Radiology UK Workforce Census 2020 Report from The Royal College of Radiologists
The Royal College of Radiologists' (RCR) latest Clinical Radiology UK Workforce Census 2020 Report reveals the significant challenges facing the breast radiologist workforce, with new figures highlighting that:
28 Apr 2021
We welcome the approval of trastuzumab deruxtecan for use on the Cancer Drugs Fund
The National Institute for Health and Care Excellence (NICE) has today - 20 April 2021 - announced its decision to recommend breast cancer drug trastuzumab deruxtecan (Enhertu) for use on the NHS in England via the Cancer Drugs Fund.
20 Apr 2021
We respond to NHS England breast cancer waiting times: February 2021
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now said:
15 Apr 2021
We welcome introduction of new treatment method for HER2 positive breast cancer by NHS England
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
04 Apr 2021
We respond to new study into early-stage breast cancer treatment in UK during initial months of COVID-19 pandemic
Responding to a new study into the treatment of early breast cancer in the UK, between March and May 2020, led by the University of Manchester and published in The British Journal of Cancer, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
29 Mar 2021
We respond to a new study about lifestyle and breast cancer risk
A new study funded by the World Cancer Research Fund (WCRF) examined people’s exposure to modifiable risk factors using data from the Health Surveys of England, Scotland, Wales, and Northern Ireland, as well as from two other ongoing studies, including the UK Biobank database. The study suggests that lifestyle factors are responsible for 27% of breast cancer cases in women.
25 Mar 2021
We respond to NHS England breast cancer waiting times: January 2021
NHS England cancer waiting times data from January 2021, published on Thursday 11 March 2021, shows:
15 Mar 2021
We respond to a study from King's College London into the effectiveness of the Pfizer COVID-19 vaccine for people with cancer
Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said:
11 Mar 2021